Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Vaneltix Pharma, Inc. See All Filings	D	2024-01-24 11:13:11 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0000932352 Filed Document 0000932352-24-000002 Exclusions or Exemptions 506b Accepted Date 2024-01-24 11:13:11 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Urigen Pharmaceuticals, Inc. See All Filings	D	2020-11-20 13:08:03 UTC
Amount To Be Raised $3,021,843 Associated Brokers / Dealers N/A CIK Number 0000932352 Filed Document 0000932352-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-11-20 13:08:03 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Urigen Pharmaceuticals, Inc. See All Filings	D	2018-02-07 10:31:02 UTC
Amount To Be Raised $1,377,000 Associated Brokers / Dealers None CIK Number 0000932352 Filed Document 0000932352-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-02-07 10:31:02 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Urigen Pharmaceuticals, Inc. See All Filings	D	2017-04-13 12:28:55 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0000932352 Filed Document 0000932352-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-04-13 12:28:55 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Debt
Urigen Pharmaceuticals, Inc. See All Filings	D	2015-07-14 00:00:00 UTC
Amount To Be Raised $12,365,759 Associated Brokers / Dealers N/A CIK Number 0000932352 Filed Document 0001144204-15-042368 Exclusions or Exemptions 506b Accepted Date 2015-07-14 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Urigen Pharmaceuticals, Inc. See All Filings	D/A	2013-10-04 00:00:00 UTC
Amount To Be Raised $856,000 Associated Brokers / Dealers N/A CIK Number 0000932352 Filed Document 0000932352-13-000003 Exclusions or Exemptions 506b Accepted Date 2013-10-04 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business DELAWARE Revenue or Assets Decline to Disclose Type of Security Debt